Correspondence 0001493152-23-002039 from PALISADE BIO, INC. (PALI)
PALISADE BIO, INC.
Date: Jan. 20, 2023 · CIK: 0001357459 · Accession: 0001493152-23-002039
AI Filing Summary & Sentiment
File numbers found in text: 333-269234
Show Raw Text
CORRESP
1
filename1.htm
Palisade
Bio, Inc.
7750
El Camino Real, Suite 5200
Carlsbad,
CA 92009
January
20, 2023
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F. Street, N.E.
Washington,
D.C. 20549
Attn:
Lauren Hamill
Re:
Palisade Bio, Inc. (the “Company”)
Registration Statement on Form S-1
Filed: January 13, 2023
File No.: 333-269234
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Securities and Exchange Commission (the
“Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1, to become effective
at 4:00 pm Eastern Time on January 24, 2023, or as soon thereafter as is practicable.
If
you have any questions regarding this request, please contact Dennis Gluck of Silvestre Law Group, P.C. at (818) 597-7552.
Very
truly yours,
PALISADE
BIO, INC.
/s/
J.D. Finley
J.D.
Finley
Chief
Executive Officer